Synergy Innovation Co., Ltd. (KOSDAQ:048870)
South Korea · Delayed Price · Currency is KRW | Market Cap | 177.98B -19.7% |
| Revenue (ttm) | 113.05B +24.8% |
| Net Income | 3.01B -71.0% |
| EPS | 35.00 -72.0% |
| Shares Out | 88.11M |
| PE Ratio | 57.71 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 136,570 |
| Average Volume | 260,587 |
| Open | 2,010.00 |
| Previous Close | 2,010.00 |
| Day's Range | 1,985.00 - 2,020.00 |
| 52-Week Range | 1,925.00 - 4,640.00 |
| Beta | 0.11 |
| RSI | 42.31 |
| Earnings Date | Apr 3, 2026 |
About Synergy Innovation
Synergy Innovation Co., Ltd. engages in the research and development, and investment of generic and new drugs, medical devices, and health functional foods in South Korea. It produces and sells various culture media for hospitals, pharmaceuticals, and food/cosmetics; manufactures synergy innovation – universal transport solutions (SI-UTS); and invests and develops in various fields comprising microorganism, bacteria, and virus. The company also provides pharmaceutical formulations; and develops non-vascular stents. Synergy Innovation Co., Ltd. ... [Read more]
Financial Performance
In 2025, Synergy Innovation's revenue was 113.05 billion, an increase of 24.77% compared to the previous year's 90.61 billion. Earnings were 3.01 billion, a decrease of -70.96%.
Financial StatementsNews
Leonardo DaVinci Meets Bungee Jumping: The Curious Origins A World-Leading Cannabis Vaporization Brand
“I’ve always been an adventure seeker,” says Cort Smith. Those words encapsulate the driving force behind a career that thrives on calculated risks and breakthrough developments. As the founder of Syn...
Tony Stark's Choice Vape? Synergy Innovation's Strategic Move To Restore Brands' Identity, Lead Market Niche
Synergy Innovation , recently launched as a house of brands, is making waves in the cannabis accessories sector with its acquisition of DaVinci and Eyce . This new venture marks a significant return t...